Agile Therapeutics, Inc. (AGRX)

0.1889 +0.0008 (+0.43%) As of 03:33PM EST. Market open.

Agile Therapeutics, Inc.

500 College Road East
Suite 310
Princeton, NJ 08540
United States
609 683 1880
https://www.agiletherapeutics.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 30

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Alfred F. Altomari	Chairman & CEO	804.82k	N/A	1959
Mr. Geoffrey P. Gilmore	Chief Admin. Officer	555.21k	N/A	1966
Dr. Paul Korner M.B.A., M.D.	Sr. VP & Chief Medical Officer	574.59k	N/A	1966
Mr. Jason Butch	Principal Financial Officer, VP & Chief Accounting Officer	N/A	N/A	N/A
Matthew Riley	Head of Investor Relations & Corp. Communications	N/A	N/A	N/A
Mr. Robert G. Conway M.E.	Chief Corp. Planning & Supply Chain Officer	N/A	N/A	1957
Dr. Elizabeth Ijeoma Onyemelukwe Garner M.D., M.P.H.	Consultant	N/A	N/A	1968
Ms. Amy Welsh	Chief Commercial Officer	N/A	N/A	N/A
Joseph D'Urso	Controller	N/A	N/A	N/A
Dr. Kathryn MacFarlane Pharm.D.	Advisor	N/A	N/A	1966

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.

Corporate Governance

Agile Therapeutics, Inc.’s ISS Governance QualityScore as of December 1, 2022 is 7. The pillar scores are Audit: 7; Board: 7; Shareholder Rights: 8; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.